On October 10, 2023, K-DOC formalized a strategic alliance with RecenseMedical Co., Ltd. (CEO Gun-ho Kim) by signing a Memorandum of Understanding (MOU) at the RecenseMedical headquarters located in Dongtan. This pivotal agreement is aimed at bolstering mutual cooperation between the two organizations, with the objective of amplifying their footprint in the international medical technology and service arenas.
RecenseMedical is at the forefront of innovation with its proprietary TargetCool technology, a state-of-the-art precision cooling solution derived from its advanced rapid precision cooling technology. The company is redefining the standards for premium aesthetic procedures within the plastic surgery and dermatology sectors across 24 countries, including the USA, Europe, the Middle East, and Southeast Asia. This collaboration with K-DOC is poised to significantly contribute to the growth and influence of the global medical market.
Under the terms of the MOU, both entities are committed to the development of cutting-edge medical technologies and services. This collaboration will encompass clinical research leveraging RecenseMedical’s rapid precision cooling technology and the facilitation of efficient and accurate clinical trials through K-DOC’s extensive network of over 5,100 medical professionals.
A spokesperson for RecenseMedical commented on the partnership, stating, "Our ongoing efforts to solidify our presence in the international market through exclusive distribution agreements in 24 countries will be greatly enhanced by this partnership. We are committed to leveraging this collaboration to elevate the global competitiveness of the domestic medical industry."
On October 10, 2023, K-DOC formalized a strategic alliance with RecenseMedical Co., Ltd. (CEO Gun-ho Kim) by signing a Memorandum of Understanding (MOU) at the RecenseMedical headquarters located in Dongtan. This pivotal agreement is aimed at bolstering mutual cooperation between the two organizations, with the objective of amplifying their footprint in the international medical technology and service arenas.
RecenseMedical is at the forefront of innovation with its proprietary TargetCool technology, a state-of-the-art precision cooling solution derived from its advanced rapid precision cooling technology. The company is redefining the standards for premium aesthetic procedures within the plastic surgery and dermatology sectors across 24 countries, including the USA, Europe, the Middle East, and Southeast Asia. This collaboration with K-DOC is poised to significantly contribute to the growth and influence of the global medical market.
Under the terms of the MOU, both entities are committed to the development of cutting-edge medical technologies and services. This collaboration will encompass clinical research leveraging RecenseMedical’s rapid precision cooling technology and the facilitation of efficient and accurate clinical trials through K-DOC’s extensive network of over 5,100 medical professionals.
A spokesperson for RecenseMedical commented on the partnership, stating, "Our ongoing efforts to solidify our presence in the international market through exclusive distribution agreements in 24 countries will be greatly enhanced by this partnership. We are committed to leveraging this collaboration to elevate the global competitiveness of the domestic medical industry."